Pierce Robert Hamilton insider trades
Pierce Robert Hamilton has filed 3 Form 4s with the SEC that we hold, all for Faeth Therapeutics, Inc. (SNSE), as Chief R&D Officer. Across all of them we count 0 purchases worth $0 and 4 sales worth $686.0K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 66,350 shares of Faeth Therapeutics, Inc. worth $473.1K, dated 2021-08-10. The first filing on our record is dated 2021-08-10 and the latest 2022-02-17.
Faeth Therapeutics, Inc. (SNSE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-06 | S, sale reported on Form 4 | 6,460 | $45.9K | 2021-08-10 |
| 2021-08-09 | S, sale reported on Form 4 | 6,982 | $49.3K | 2021-08-10 |
| 2021-08-10 | S, sale reported on Form 4 | 66,350 | $473.1K | 2021-08-10 |
| 2021-08-11 | S, sale reported on Form 4 | 16,030 | $117.7K | 2021-08-12 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1594129) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms